Details for New Drug Application (NDA): 008102
✉ Email this page to a colleague
The generic ingredient in TACE is chlorotrianisene. There are four drug master file entries for this compound. Additional details are available on the chlorotrianisene profile page.
Summary for 008102
Tradename: | TACE |
Applicant: | Sanofi Aventis Us |
Ingredient: | chlorotrianisene |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 008102
Profile for product number 004
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 12MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription